
Keywords: CED; convection-enhanced delivery; BBB; blood-brain barrier; ACNU; nimustine hydrochloride; BCNU; carmustine; PLD; PEGylated liposomal doxorubicin; PBS; phosphate buffered saline; DAPI; 4â²,6-diamidino-2-phenylindole; NeuN; neuronal nuclear antigen; Br